EP300 and posterior cortical atrophy: Whereas p300 ablation abrogated MHC-I AgPP induction and the synergy between low-dose Oxali and PD-(L)1 blockade, it had no effect on induction of antitumor immunity by Oxali-killed PCa cells used as an immunogen.